| scholarly article | Q13442814 |
| P356 | DOI | 10.1155/2015/704946 |
| P2093 | author name string | Munira Momin | |
| Kamalinder K. Singh | |||
| Premanand Nighojkar | |||
| Sonali Askarkar | |||
| Suvarna P. Phadatare | |||
| P2860 | cites work | Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study | Q28270236 |
| Non-invasive methods of assessing the tear film | Q33202232 | ||
| Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity. | Q33363001 | ||
| Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial | Q33543585 | ||
| Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies | Q33720070 | ||
| Mechanisms of action of cyclosporine. | Q33908049 | ||
| Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. | Q33935309 | ||
| The diagnosis and management of dry eye: a twenty-five-year review | Q34048201 | ||
| Aging: a predisposition to dry eyes. | Q34114336 | ||
| Regulation of ocular mucin secretion by P2Y2 nucleotide receptors in rabbit and human conjunctiva. | Q50522217 | ||
| Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. | Q50933029 | ||
| Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. | Q52250855 | ||
| Tear function parameters in keratoconjunctivitis sicca with and without the association of Sjögren's syndrome. | Q52580433 | ||
| Sjogren's syndrome | Q55970263 | ||
| Impact of symptomatic dry eye on vision-related daily activities: The Singapore Malay Eye Study | Q56775843 | ||
| Cyclosporine A Loaded PLGA Nanoparticles for Dry Eye Disease:In VitroCharacterization Studies | Q59060927 | ||
| Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome | Q39422825 | ||
| Prevalence of dry eye among the elderly | Q39457390 | ||
| Meibomian gland dysfunction | Q41089196 | ||
| Cyclosporin pro-dispersion liposphere formulation. | Q41614289 | ||
| Ophthalmic drug delivery systems--recent advances | Q41736662 | ||
| Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye. | Q42684410 | ||
| Gefarnate stimulates mucin-like glycoprotein secretion in conjunctival tissue and ameliorates corneal epithelial damage in animal dry-eye models | Q43148458 | ||
| Tear proteomics in evaporative dry eye disease | Q43600799 | ||
| Hormone replacement therapy and dry eye syndrome | Q43788868 | ||
| Evaluation of topical cyclosporine for the treatment of dry eye disease | Q44443222 | ||
| The repeatability of clinical measurements of dry eye. | Q44845090 | ||
| The ocular surface in keratoconjunctivitis sicca | Q45053753 | ||
| Prevalence and treatment of Helicobacter pylori in patients with blepharitis. | Q45164354 | ||
| Dry eye disease and work productivity loss in visual display users: the Osaka study | Q45191438 | ||
| Conjunctival surface damage distribution in keratoconjunctivitis sicca. An impression cytology study. | Q45280477 | ||
| Correlation between dry eye and rheumatoid arthritis activity | Q46805153 | ||
| Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction | Q46863578 | ||
| Abnormal protein profiles in tears with dry eye syndrome | Q34218114 | ||
| Essential fatty acids in the treatment of dry eye syndrome: A myth or reality? | Q34273267 | ||
| Dry eye disease: A review of diagnostic approaches and treatments | Q34273384 | ||
| The lipid layer of tears: dependent on meibomian gland function | Q34316114 | ||
| Clinical manifestations and early diagnosis of Sjögren syndrome | Q34330087 | ||
| A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye. | Q34332957 | ||
| A review of quality of life measures in dry eye questionnaires | Q34364536 | ||
| Diagnosis of dry eye. | Q34391935 | ||
| Computer vision syndrome: a review. | Q34413625 | ||
| Improving awareness, identification, and management of meibomian gland dysfunction | Q34433186 | ||
| Topical omega-3 and omega-6 fatty acids for treatment of dry eye. | Q34749224 | ||
| CA 19-9 ELISA test: a new method for studying mucus changes in tears. | Q35301950 | ||
| Diseases associated with ocular surface abnormalities: the importance of reflex tearing | Q35306846 | ||
| Grading Of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests | Q35542950 | ||
| Tears in health and disease | Q35590404 | ||
| Autologous serum eye drops for ocular surface disorders | Q35592577 | ||
| Impact of dry eye syndrome on vision-related quality of life | Q35741609 | ||
| The role of the lacrimal functional unit in the pathophysiology of dry eye. | Q35755146 | ||
| Impression cytology of the ocular surface: a review. | Q35755167 | ||
| Changes in the tear film and ocular surface from dry eye syndrome | Q35818760 | ||
| Dry eye diagnosis and management in 2004. | Q35825728 | ||
| The use of mucoadhesive polymers in ocular drug delivery | Q36273784 | ||
| Tear mucus ferning in patients with Sjögren's syndrome | Q36713766 | ||
| Regulatory T cells and the eye. | Q36722816 | ||
| Pharmacological management of dry eye in the elderly patient | Q37079081 | ||
| Classification and diagnosis of dry eye. | Q37153418 | ||
| Advances in understanding and managing dry eye disease | Q37206550 | ||
| Polymeric nanoparticulate system: a potential approach for ocular drug delivery | Q37426784 | ||
| Recent developments on dry eye disease treatment compounds | Q37581630 | ||
| Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life | Q37715859 | ||
| The international workshop on meibomian gland dysfunction: executive summary | Q37859542 | ||
| Computer vision syndrome: a review of ocular causes and potential treatments | Q37863704 | ||
| Diquafosol ophthalmic solution for dry eye treatment | Q38030453 | ||
| Rethinking dry eye disease: a perspective on clinical implications | Q38203969 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | eye disease | Q3041498 |
| diagnosis | Q16644043 | ||
| P304 | page(s) | 1-12 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Advances in Pharmaceutics | Q50812042 |
| P1476 | title | A Comprehensive Review on Dry Eye Disease: Diagnosis, Medical Management, Recent Developments, and Future Challenges | |
| P478 | volume | 2015 |
| Q38769216 | Development towards Compact Nitrocellulose-Based Interferometric Biochips for Dry Eye MMP9 Label-Free In-Situ Diagnosis |
| Q38974479 | Nurses can play an active role in the early diagnosis of exposure keratopathy in intensive care patients |
| Q36835236 | Repeatability and Reproducibility of Noninvasive Keratograph 5M Measurements in Patients with Dry Eye Disease |
| Q38884551 | Serum eye drops: a survey of international production methods. |
Search more.